Skip to main content
Ikonisys S.A. logo

Ikonisys S.A. — Investor Relations & Filings

Ticker · ALIKO ISIN · FR00140048X2 LEI · 9695000B742KPNDQ4D05 PA Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2024-10-10 Regulatory Filings
Country FR France
Listing PA ALIKO

About Ikonisys S.A.

https://www.ikonisys.com

Ikonisys S.A. is a cell-based diagnostics company specializing in Fluorescence in Situ Hybridization (FISH) technology for genetic analysis. The company develops, manufactures, and markets integrated solutions that include proprietary automated microscopy instruments, advanced software, and reagents. These systems are designed to improve efficiency, accuracy, and standardization for pathologists and laboratory technicians. Ikonisys's technology enables the precise detection and analysis of chromosomal alterations, supporting early and accurate cancer diagnosis, prognosis, and the selection and monitoring of personalized therapies. The platform's automation and digitization features streamline the entire workflow from image acquisition to quantitative interpretation for oncology and genetic testing applications.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 100% confidence The document is a press release announcing a specific business event: Hospitex International (a subsidiary of Ikonisys) winning a public tender in Italy for diagnostic systems, valued at nearly €400,000. It includes quotes from management, details about the contract, and standard 'About Us' sections and disclaimers. This type of announcement, detailing a significant business contract win or operational milestone, does not fit the specific definitions for financial reports (10-K, IR, ER), regulatory filings (DEF 14A, DVA), or shareholder actions (DIV, SHA). It is a general corporate announcement. Since there is no specific category for 'Business Contract Win Announcement,' the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for miscellaneous corporate announcements that are not covered by the more specific codes.
2024-10-10 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 100% confidence The document is a press release dated October 10, 2024, announcing that Ikonisys's subsidiary, Hospitex International, won a tender (appel d'offres) in Italy for supplying diagnostic systems. This announcement details a significant business contract win and provides updates on the company's operations and market positioning. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It is a specific business update that doesn't fit the definitions for M&A (TAR), Director's Dealing (DIRS), or Capital Changes (CAP). Since it is a general announcement regarding a significant business event (winning a contract), it best fits the 'Regulatory Filings' (RNS) category as a general corporate announcement, or potentially a general 'LTR' if it were related to legal/regulatory matters, but here it is purely commercial news. Given the options, RNS serves as the best general announcement/press release category for significant, non-standardized corporate news.
2024-10-10 French
Informations privilégiées / Autres communiqués
Environmental & Social Information Classification · 99% confidence The document is a press release dated October 3, 2024, announcing that Ikonisys SA has successfully maintained its ISO 13485 certification following an audit with no non-conformities. This announcement relates to the company's quality management system for medical devices and its compliance with regulatory standards (CE marking, FDA requirements). This type of announcement, which details operational compliance, quality assurance, and regulatory status without being a full financial report (like 10-K or IR) or a specific management change, best fits the category for general regulatory or operational updates. Since it is a specific announcement about quality/regulatory compliance rather than a general regulatory filing fallback (RNS), and it is not a formal Audit Report (AR) which usually implies the full report itself, it is classified as a Regulatory Filing (RNS) as a broad category for operational news releases that don't fit the highly specific financial or corporate action codes. However, given the focus on quality management systems and regulatory adherence, it is a specific operational update. Since there is no specific code for 'Quality Certification Announcement', and it is not an Earnings Release (ER), Management Discussion (MDA), or Audit Report (AR), RNS (Regulatory Filings - general/miscellaneous) is the most appropriate fallback, although it is a very specific operational announcement. Given the context of maintaining a critical quality standard (ISO 13485) essential for market access, it is a significant operational/regulatory update. I will use RNS as the best fit among the provided options for a non-financial, non-governance, non-management specific press release.
2024-10-03 French
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release dated October 3, 2024, announcing the successful maintenance of the company's ISO 13485 certification. It discusses operational milestones, regulatory compliance (FDA, CE marking, EU IVDR), and strategic positioning. This type of announcement, which details operational achievements, regulatory status, or minor corporate news that doesn't fit a specific financial report (like 10-K, ER, or IR), is best classified as a general Regulatory Filing (RNS) or potentially a general announcement. Since it is not a formal financial report, a management discussion, an earnings release, or a specific shareholder communication, RNS serves as the most appropriate general regulatory announcement category.
2024-10-03 English
Inside Information / Other news releases
AGM Information Classification · 99% confidence The document explicitly announces the results of the company's 'Ordinary Annual and Extraordinary General Meeting' held on September 30, 2024. It states that all resolutions, including the approval of financial statements, were adopted. This content directly relates to the outcomes of a shareholder meeting, which corresponds to the 'Declaration of Voting Results & Voting Rights Announcements' category.
2024-10-01 English
Informations privilégiées / Autres communiqués
AGM Information Classification · 99% confidence The document is titled "Ikonisys annonce les résultats de son Assemblée générale ordinaire annuelle et extraordinaire du 30 septembre 2024" (Ikonisys announces the results of its Annual Ordinary and Extraordinary General Meeting of September 30, 2024). It explicitly states that all resolutions presented at the General Meeting were adopted by the shareholders. This content directly relates to the official results from a shareholder vote at a general meeting. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (2805 chars), but its primary purpose is reporting the outcome of the vote, not just announcing the publication of a report.
2024-10-01 French

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.